Keith A. Ching
Pfizer (United States)(US)
Publications by Year
Research Areas
Protein Tyrosine Phosphatases, RNA modifications and cancer, Biochemical and Molecular Research, Cancer Immunotherapy and Biomarkers, CAR-T cell therapy research
Most-Cited Works
- → A gene atlas of the mouse and human protein-encoding transcriptomes(2004)3,516 cited
- → Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome(2007)3,447 cited
- → Histone modifications at human enhancers reflect global cell-type-specific gene expression(2009)2,565 cited
- → Large-scale analysis of the human and mouse transcriptomes(2002)1,485 cited
- → Analysis of the Vertebrate Insulator Protein CTCF-Binding Sites in the Human Genome(2007)1,048 cited
- → Avelumab plus axitinib versus sunitinib in advanced renal cell carcinoma: biomarker analysis of the phase 3 JAVELIN Renal 101 trial(2020)506 cited
- → Ubiquitin-mediated sequestration of normal cellular proteins into polyglutamine aggregates(2003)224 cited
- → A Comparison of the Celera and Ensembl Predicted Gene Sets Reveals Little Overlap in Novel Genes(2001)189 cited
- → Chemotherapy induces dynamic immune responses in breast cancers that impact treatment outcome(2020)183 cited
- → Natural variants of the human papillomavirus type 16 E6 protein differ in their abilities to alter keratinocyte differentiation and to induce p53 degradation(1996)154 cited